Please assess the completion status of the following clinical trial:

Trial Title: Peroperative Assessment of Tumour Resection Margins Using High-resolution 18F-FDG-PET/CT in Pancreatic Adenocarcinoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients (≥ 18 years)~* Signed informed consent~* Patient with a Pancreas Ca who is undergoing Whipple surgery~* Patient with ASA grade 1 to 3~Exclusion Criteria:~* Patient has ASA 4~* Patient under long-term use of anticoagulant therapy (except low dose aspirin)~* Patient has tumor invasion of blood vessels~* The patient undergoes a total pancreatectomy~* Patient undergoes a double derivation~* pregnant or breastfeeding woman

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- test group (Type: OTHER): All patients who give their consent for this study will participate in the test group and will therefore receive the injection with 18F-FDG and images (PET / CT) will be made of the resection piece.

Based on this trial design, predict the completion outcome and termination type (if applicable).